Dark

CDNA
CareDx, Inc.
stock NASDAQ

Market Open

Jul 16, 2026 10:54:07 AM EDT

37.06USD+24.571%(+7.31)1,594,223

31.81Bid 42.87Ask 11.06Spread

Pre-market

Jul 16, 2026 9:28:30 AM EDT

35.55USD+19.496%(+5.80)146,335

After-hours

Jul 15, 2026 4:20:30 PM EDT

29.90USD+0.504%(+0.15)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 20, 2022

05:05PM EST Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

07:00AM EST CareDx Joins Forces with MOTTEP to Increase Organ Donations for GlobeNewswire Inc

Jan 12, 2022

07:00AM EST ADMIRAL Study Shows AlloSure Detects Clinical and Subclinical ABMR and TCMR, and Predicts Long-Term Outcomes for Kidney Transplant Patients GlobeNewswire Inc

Jan 11, 2022

07:10AM EST CareDx Partners With Multiple Biotechnology Companies To Use AlloCell In CAR T-Cell Therapy Clinical Studies Benzinga

07:00AM EST CareDx Partners with Multiple Biotechnology Companies to Use GlobeNewswire Inc

Jan 10, 2022

07:09AM EST CareDx Sees Q4 Sales $78.6M-$79M Vs. $75.63M Est., FY21 Sales $295.7M-$296.1M Vs. $292.78M Est. Benzinga

07:00AM EST CareDx, Inc.(Nasdaq: CDNA) -- The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021. GlobeNewswire Inc

Jan 7, 2022

01:02PM EST CareDx Highlights National Institutes Of Health Study Showed Co.'s AlloSure For Transplant Surveillance Is More Effective Than Diagnostic Bronchoscopy At Identifying Rejection Benzinga

07:00AM EST NIH Study Shows Using CareDxs AlloSure Lung for GlobeNewswire Inc

Jan 6, 2022

07:15AM EST CareDx Successfully Completes CLIA Validation Of AlloMap Kidney In Preparation For Commercial Launch Benzinga

07:00AM EST CareDx Successfully Completes CLIA Validation of AlloMap Kidney in GlobeNewswire Inc

Jan 5, 2022

07:00AM EST CareDx Expands Its Medication Adherence Services with the GlobeNewswire Inc

Jan 4, 2022

07:00AM EST CareDx Partners with ISHLT in a Transplant Innovation Research GlobeNewswire Inc

Dec 27, 2021

05:13PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CareDx, Inc. (CareDx or the Company) (NASDAQ: CDNA) on behalf of CareDx stockholders. Our investigation concerns whether CareDx has violated the federal securities laws and/or engaged in other unlawful business practices. GlobeNewswire Inc

02:41PM EST Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

Dec 22, 2021

09:00PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CareDx, Inc. (CareDx or the Company) (NASDAQ: CDNA) on behalf of CareDx stockholders. Our investigation concerns whether CareDx has violated the federal securities laws and/or engaged in other unlawful business practices. GlobeNewswire Inc

Dec 16, 2021

07:03AM EST CareDx Enrolls First Patient In LungCare Registry Study To Measure Impact Of Multimodality Assessment On Lung Transplant Patient Outcomes Benzinga

07:00AM EST CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the enrollment of the first patient in the multicenter, observational, prospective ALAMO registry to improve lung transplant patient care. GlobeNewswire Inc

Dec 13, 2021

07:15AM EST CareDx Partners With The North American Pediatric Renal Trials And Collaborative Studies Organization In Launching Prospective, Multi-Center Pediatric Kidney Transplant Study Benzinga

07:00AM EST CareDx Partners with the North American Pediatric Renal Trials and GlobeNewswire Inc

Dec 12, 2021

Dec 7, 2021

04:00PM EST Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

Dec 2, 2021

06:38PM EST Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

07:07AM EST CareDx The Transplant Company Surpasses 80,000 Patient Milestone Benzinga

07:00AM EST CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today announced that it has served over 80,000 organ transplant patients with AlloSure or AlloMap for their post-transplant care.1 GlobeNewswire Inc

Nov 27, 2021

05:00AM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CareDx, Inc. (CareDx or the Company) (NASDAQ: CDNA) on behalf of CareDx stockholders. Our investigation concerns whether CareDx has violated the federal securities laws and/or engaged in other unlawful business practices. GlobeNewswire Inc

Nov 23, 2021

04:42PM EST Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

Nov 19, 2021

07:00AM EST CareDx Named One of the Fastest-Growing Companies in North America GlobeNewswire Inc

Nov 18, 2021

07:04AM EST CareDx Enrolls First Patients In The Largest Digital Study In Transplant Using AlloCare To Assess Patient Outcomes Benzinga

07:00AM EST TEAMMATE Study to Assess Impact in 4,000 Patients Across100 Transplant Centers GlobeNewswire Inc

Nov 15, 2021

04:05PM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announcedtoday the Company will participate in the 12th Annual Jefferies London Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference. GlobeNewswire Inc

Nov 10, 2021

07:52AM EST CareDx Acquires MedActionPlan; No Terms Disclosed Benzinga

07:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has acquired MedActionPlan, a New Jersey-based provider of medication safety and adherence technology and patient education. GlobeNewswire Inc

Nov 4, 2021

07:00AM EDT University of Alabama Integrates CareDxs GlobeNewswire Inc

Nov 3, 2021

02:47PM EDT Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

07:00AM EDT CareDx Focuses on Innovation in Transplant atASN GlobeNewswire Inc

Nov 1, 2021

04:01PM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the company has completed its transition from Peter Maag, PhD, to Reginald Seeto, MBBS, as Chief Executive Officer. GlobeNewswire Inc

09:04AM EDT Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Oct. 29, 2021: NTLA, PACB, ACHR, MKFG, BLDE, FB, CDNA, DOC, EXAS, VERV, BEAM Benzinga

Oct 30, 2021

11:31AM EDT Significant Losses to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations PR Newswire

Oct 29, 2021

05:18PM EDT Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now. GlobeNewswire Inc

02:38PM EDT Mid-Afternoon Market Update: Gold Down 1%; A10 Networks Shares Gain Following Q3 Results Benzinga

12:21PM EDT Mid-Day Market Update: Dow Rises 50 Points; Onion Global Shares Plummet Benzinga

10:02AM EDT Raymond James Maintains Strong Buy on CareDx, Lowers Price Target to $90 Benzinga

Oct 28, 2021

04:41PM EDT CareDx: Q3 Earnings Insights Benzinga

04:18PM EDT CareDx Sees FY21 Revenues $290M-$293M Vs $290.39M Est Benzinga

04:16PM EDT CareDx Raises Guidance Benzinga

04:13PM EDT CareDx Q3 EPS $0.07 Beats $0.01 Estimate, Sales $75.59M Beat $74.05M Estimate Benzinga

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 21, 2021

07:00AM EDT CareDxs AlloSure Demonstrates Better Accuracy GlobeNewswire Inc

Oct 19, 2021

07:30AM EDT CareDx And Eledon Pharmaceuticals Announce Collaborative Research Agreement Benzinga

07:00AM EDT CareDx and Eledon Pharmaceuticals Announce Collaborative Research GlobeNewswire Inc

Oct 14, 2021

04:01PM EDT CareDx to Report Third Quarter 2021 Financial Results GlobeNewswire Inc

Oct 12, 2021

10:21AM EDT CareDx Says AlloSure Launches For Lung Transplant Patients Benzinga

10:19AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the commercial launch of AlloSure Lung to coincide with the CHEST 2021 Meeting starting on October 16. GlobeNewswire Inc

Sep 30, 2021

04:01PM EDT CareDx Extends Leadership in Multimodality Transplant Care with GlobeNewswire Inc

Sep 28, 2021

07:18PM EDT False Advertising Lawsuit Against Natera is Set to Go to Trial GlobeNewswire Inc

Sep 27, 2021

07:02AM EDT CareDx Presents Latest Data On AlloSeq Portfolio At ASHI 2021 Benzinga

Sep 15, 2021

08:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of patient advocate, political leader, and former state senator Art Torres to its Board of Directors. GlobeNewswire Inc

Sep 9, 2021

08:00AM EDT Miromatrix Welcomes Dr. John Barry as Vice President of Research GlobeNewswire Inc

Sep 2, 2021

07:00AM EDT CareDx to Participate in Upcoming Conferences GlobeNewswire Inc

Aug 26, 2021

07:00AM EDT CareDx Showcases Leadership in Global Transplantation at ESOT 2021 GlobeNewswire Inc

Aug 11, 2021

07:38AM EDT Miromatrix Medical Reports Strategic Investors Were Involved In Series C Financing Following IPO: Baxter, CareDx, DaVita; No Size Of Investment Disclosed Benzinga

07:00AM EDT Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients' lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO. GlobeNewswire Inc

Jul 29, 2021

04:49PM EDT CareDx Raises FY21 Sales Guidance From $270M-$280M To $280M-$290M vs $278.39M Est. Benzinga

04:48PM EDT CareDx Q2 Adj. EPS $0.11 Beats $0.02 Estimate, Sales $74.19M Beat $67.55M Estimate Benzinga

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

Jul 26, 2021

07:00AM EDT CareDx Launches ACROBAT Study to Potentially Change Care Paradigm GlobeNewswire Inc

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 19, 2021

07:40AM EDT Medexus Appoints New Chief Financial Officer GlobeNewswire Inc

Jul 15, 2021

10:43AM EDT Craig Hallum On CareDx Says Centers For Medicare & Medicaid Services Has Issued Billing, Coding Document Clarifying Prior Language, Says Document Issued Today Clarified Both AlloMap Heart, AlloSure Heart Are Both Covered When Used Together Benzinga

07:00AM EDT CareDx to Report Second Quarter 2021 Financial Results GlobeNewswire Inc

Jul 1, 2021

04:01PM EDT CareDx Transplant Patient App, AlloCare, Launches On Android Benzinga

04:01PM EDT CareDx Transplant Patient App, AlloCare, Expands Access to the GlobeNewswire Inc

Jun 30, 2021

07:17AM EDT CareDx Appoints Hannah Valantine To Board RTTNews

07:00AM EDT Dr. Valantine brings deep transplant and diversity leadership expertise to the CareDx board GlobeNewswire Inc

Jun 28, 2021

07:27AM EDT Raymond James Maintains Strong Buy on CareDx, Raises Price Target to $108 Benzinga

Jun 17, 2021

07:00AM EDT CareDx CEO Reg Seeto to Present at AAKP 4th Annual Policy Summit GlobeNewswire Inc

Jun 16, 2021

07:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the Raymond James 2021 Human Health Innovation Conference. GlobeNewswire Inc

Jun 15, 2021

07:00AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it is hosting a virtual fireside chat with Erik Compton, professional golfer and two-time heart transplant recipient, on June 15. GlobeNewswire Inc

Jun 9, 2021

07:00AM EDT CareDx congratulates Hannah Valantine for her State of the Art GlobeNewswire Inc

Jun 8, 2021

07:11AM EDT CareDx Acquires Transplant Hero LLC RTTNews

07:10AM EDT CareDx To Acquire Transplant Hero; Terms Not Disclosed Benzinga

07:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has acquired Transplant Hero LLC, a New York-based provider of a mobile application supporting the needs of transplant patients. GlobeNewswire Inc

Jun 7, 2021

07:00AM EDT CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher GlobeNewswire Inc

Jun 4, 2021

07:00AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its participation in the 2021 American Transplant Congress (ATC), including two symposia and the presentation of 40 scientific abstracts. GlobeNewswire Inc

Jun 3, 2021

10:09AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 Benzinga

07:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the 42nd Annual Goldman Sachs Global Healthcare Conference. GlobeNewswire Inc

06:33AM EDT Goldman Sachs Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $95 Benzinga

Jun 1, 2021

08:25AM EDT CareDx Begins Enrollment In MAPLE Prospective Study Of LiverCare RTTNews

08:16AM EDT CareDx Starts Enrollment In MAPLE, A Multi-Modal, Multi-Center, Prospective Study Of LiverCare Benzinga

08:10AM EDT CareDx Starts Enrollment in MAPLE, a Multi-modal, Multi-center, GlobeNewswire Inc

May 28, 2021

06:00PM EDT CareDx Announces Strategic Minority Investment in Miromatrix GlobeNewswire Inc

May 27, 2021

07:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the Jefferies Virtual Healthcare Conference. GlobeNewswire Inc

May 13, 2021

07:00AM EDT CareDx to Participate in AAKP and George Washington University GlobeNewswire Inc

May 6, 2021

07:50AM EDT Raymond James Maintains Strong Buy on CareDx, Lowers Price Target to $90 Benzinga

May 5, 2021

04:18PM EDT CareDx Raises FY21 Sales Guidance From $255M-$265M To $270M-$280M Vs. $260.92M Est. Benzinga

04:17PM EDT CareDx Q1 EPS $0.14, Sales $67.40M Beat $61.05M Estimate Benzinga

04:01PM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the first quarter ended March31, 2021. GlobeNewswire Inc

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

Apr 23, 2021

07:00AM EDT CareDx to Present New Heart Transplant Data at the International GlobeNewswire Inc

Apr 22, 2021

11:39AM EDT CareDx Announces Palmetto MolDx Finalized Local Coverage Determination 'Molecular Testing For Solid Organ Allograft Rejection' Benzinga

11:38AM EDT Palmetto MolDx Issues Foundational Coverage for Molecular Testing GlobeNewswire Inc

07:00AM EDT CareDx to Debut Multicenter Data on AlloSure Lung, an GlobeNewswire Inc

Apr 21, 2021

04:00PM EDT CareDx to Report First Quarter 2021 Financial Results GlobeNewswire Inc

Apr 20, 2021

07:00AM EDT CareDx Showcases Transplantation Innovation and Leadership in GlobeNewswire Inc

Apr 16, 2021

07:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will be exhibiting at the 29th Annual UNOS Transplant Management Forum (TMF), which takes place virtually between April 19-22, 2021. GlobeNewswire Inc

Apr 8, 2021

07:00AM EDT CareDx Announces New HLA Typing Service Offering for Research Purposes GlobeNewswire Inc

Apr 5, 2021

07:00AM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced its presence at the National Kidney Foundations 2021 Spring Clinical Meetings, which will take place virtually, April 6-10, 2021. GlobeNewswire Inc

Mar 31, 2021

07:00AM EDT CareDx Enhances Leadership Team with Key Appointments GlobeNewswire Inc

Mar 23, 2021

07:02AM EDT CareDx Supports Vir Biotechnology's Clinical Trial Recruitment Efforts For COMET-ICE Benzinga

07:00AM EDT CareDx Supports Vir Biotechnologys Clinical GlobeNewswire Inc

Mar 17, 2021

07:18AM EDT CareDx, Inc. (CDNA) has acquired BFS Molecular, a software company focused on NGS-based patient testing solutions. Tim Hague, CEO and Co-Founder of BFS Molecular, will join CareDx as Vice President of Global Lab Products Software. RTTNews

07:10AM EDT CareDx Acquires BFS Molecular S.R.L. RTTNews

07:00AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has acquired BFS Molecular S.R.L., a software company focused on NGS-based patient testing solutions. GlobeNewswire Inc

Mar 12, 2021

07:36AM EST The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs Benzinga

Mar 11, 2021

04:23PM EST CareDx Names Ankur Dhingra As CFO Benzinga

04:05PM EST CareDx Names Ankur Dhingra as New Chief Financial Officer GlobeNewswire Inc

Feb 26, 2021

07:02PM EST Exclusive: New CareDX CEO Reg Seeto Talks Transplantation Care Provider's Mission, Vision, Growth Drivers Benzinga

Feb 25, 2021

08:16AM EST Raymond James Maintains Strong Buy on CareDx, Lowers Price Target to $98 Benzinga

07:22AM EST CareDx Says Expands Into Pre-Transplant Kidney Space Through TX Connect Benzinga

07:00AM EST CareDx Expands into the Pre-Transplant Kidney GlobeNewswire Inc

Feb 24, 2021

04:16PM EST CareDx Sees FY21 Sales of $255M-$265M Vs. $249.81M Est. Benzinga

04:15PM EST CareDx Q4 EPS $0.08 Beats $0.02 Estimate, Sales $58.64M Beat $55.51M Estimate Benzinga

04:01PM EST CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the fourth quarter and full year ended December31, 2020. GlobeNewswire Inc

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

10:23AM EST Exclusive: New CareDX CEO Reg Seeto Talks Transplantation Care Provider's Mission, Vision, Growth Drivers Benzinga

08:40AM EST Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Feb. 23, 2021: ACB, DKNG, ABNB, ARKO, CDNA Benzinga

07:50AM EST Exclusive: New CareDX CEO Reg Seeto Talks Transplantation Care Provider's Mission, Vision, Growth Drivers Benzinga

07:45AM EST EXCLUSIVE: CareDx CEO Says Long-Term Goal Is For 75% Margin Level On Blended Basis Benzinga

07:45AM EST EXCLUSIVE: CareDx CEO Reginald Seeto, In Benzinga Interview, Sees 3 Business Drivers In 2021: Expansion To Community, Reimbursement Approval Of AlloSure Heart, Strategic Patient Care Managers Benzinga

07:00AM EST Spotlight on the CareDxs Symposium at the GlobeNewswire Inc

Feb 17, 2021

07:02PM EST Cathie Wood's ARK Invest Posts Fund Sales For Wednesday, Feb. 17, 2021: GOOGL, CDNA, TWST, VCYT, ONVO, SPLK, SSYS, BYDDY, AVAV, API, PD, PSTG, TCEHY Benzinga

Feb 12, 2021

07:00AM EST CareDx to Report Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire Inc

Feb 11, 2021

07:00AM EST CareDx Announces Full Exercise of Underwriters GlobeNewswire Inc

Feb 10, 2021

07:00AM EST CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. GlobeNewswire Inc

Feb 5, 2021

07:05AM EST CareDx Says Showcases Cellular Transplantation, Therapy Portfolio At TCT Benzinga

07:00AM EST CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT GlobeNewswire Inc

Jan 25, 2021

04:28PM EST CareDx Announces Closing of Public Offering of Common Stock GlobeNewswire Inc

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

05:32AM EST CareDx Priced 1,923,077 Share Offering of Common Stock at $91/Share Benzinga

Jan 20, 2021

10:56PM EST CareDx Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 19, 2021

04:15PM EST CareDx Announces A $175M Share Common Stock offering Benzinga

04:14PM EST CareDx Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

11:19AM EST Insider Sells CareDx's Shares Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

Jan 13, 2021

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

Jan 12, 2021

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 11, 2021

07:02AM EST CareDx Sees Q4 Sales $58.4M-$58.6M Vs. $53.21M Est., FY20 Sales $191.9M-$192.1M Vs. $186.75M Est. Benzinga

07:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported preliminary financial results for the fourth quarter and full year ended December 31, 2020. GlobeNewswire Inc

Jan 8, 2021

07:13AM EST CareDx Agrees to Acquire TransChart; Terms Not Disclosed Benzinga

07:12AM EST CareDx Agrees to Acquire TransChart and Expands EMR Connectivity GlobeNewswire Inc

07:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it will be showcasing new transplant data at the upcoming21st Annual American Society of Transplant Surgeons (ASTS) Digital Winter Symposium. GlobeNewswire Inc

Jan 7, 2021

07:09AM EST CareDx And IDbyDNA Announce Exclusive Partnership Focused On 'the development of metagenomic infectious disease testing specific to transplant patients'; Companies will Develop AlloID Tailored Infectious Disease Testing Solution Benzinga

07:00AM EST CareDx Announces AlloID and Exclusive Partnership with IDbyDNA GlobeNewswire Inc

Jan 4, 2021

07:00AM EST CareDxs AlloSeq HCT Wins Tenderfor GlobeNewswire Inc

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 22, 2020

10:00AM EST CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, applauds Congress on todays passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 (Immuno Bill). GlobeNewswire Inc

Dec 15, 2020

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

Dec 11, 2020

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

09:28AM EST Raymond James Maintains Strong Buy on CareDx, Raises Price Target to $75 Benzinga

07:42AM EST The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations Benzinga

Dec 8, 2020

08:04AM EST The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga

Dec 1, 2020

07:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the results from the first publication on the use of AlloSure in pediatric kidney transplant patients. GlobeNewswire Inc

Nov 25, 2020

07:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the Company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference. GlobeNewswire Inc

Nov 24, 2020

08:13AM EST The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia Benzinga

Nov 19, 2020

08:17AM EST The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway Benzinga

Nov 17, 2020

05:28AM EST CareDx Announced Medicare Reimbursement Pricing of $2,753 for AlloSure Heart Benzinga

05:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has received final reimbursement pricing of $2,753 from Palmetto MolDx for AlloSure Heart. GlobeNewswire Inc

Nov 10, 2020

07:00AM EST CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today that the company plans to participate in two upcoming conferences. GlobeNewswire Inc

Nov 6, 2020

07:21AM EST CareDx Highlights Publication Of AlloSure Research In 'Transplantation Direct' Journal Benzinga

07:05AM EST Research from Johns Hopkins, University of Maryland, and Cedars Sinai Shows AlloSureMay Signal BK Virus Progression in Transplant Patients GlobeNewswire Inc

07:00AM EST CareDx Joins National Kidney Foundation in Virtual Walk for Kidney GlobeNewswire Inc

Oct 30, 2020

07:49AM EDT Raymond James Maintains Strong Buy on CareDx, Raises Price Target to $62 Benzinga

07:09AM EDT HC Wainwright & Co. Maintains Buy on CareDx, Raises Price Target to $55 Benzinga

Oct 29, 2020

04:39PM EDT CareDx Q3 EPS $0.10 Up From $0.02 YoY, Sales $53.40M Beat $53.01M Estimate Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 21, 2020

07:00AM EDT CareDx Showcases Leading Transplant Data at ASN 2020 GlobeNewswire Inc

Oct 19, 2020

07:08AM EDT CareDx Announces The Centers For Medicare And Medicaid Services Recently Issued A Memo Recommending Continued Coverage Of Allomap Through Local Medicare Administrative Contractors Benzinga

07:05AM EDT Medicare Proposes to Maintain Current Reimbursement Process for GlobeNewswire Inc

07:00AM EDT CareDx Leads in Innovation with AlloSeq Portfolio at ASHI 2020 GlobeNewswire Inc

Oct 15, 2020

04:05PM EDT CareDx to Report Third Quarter 2020 Financial Results GlobeNewswire Inc

Oct 8, 2020

10:13AM EDT Shares of precision medicine solutions company CareDx, Inc (CDNA) are rising more than 15% Thursday morning after the company reported preliminary third-quarter revenue, 57% more than last year. RTTNews

07:06AM EDT HC Wainwright & Co. Maintains Buy on CareDx, Raises Price Target to $47 Benzinga

06:03AM EDT A Peek Into The Markets: US Stock Futures Climb On Stimulus Hopes Benzinga

Oct 7, 2020

05:44PM EDT GoPro Inc. (GPRO) - Shares of the action camera maker gained nearly 5% in extended session on top of its 30% rise in regular trading Wednesday. GoPro announced that its subscribers increased to over 500,000, up from 400,000 in August. It also said that the target of 600,000 to 700,000 subscribers by year-end should be exceeded if adoption rates continue as expected. RTTNews

04:06PM EDT CareDx Sees Q3 Sales ~$53M vs $44.7M Estimate Benzinga

04:05PM EDT CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced preliminary unaudited revenue for the three months ended September 30, 2020. GlobeNewswire Inc

Oct 2, 2020

08:11AM EDT 10 Biggest Price Target Changes For Friday Benzinga

07:00AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the publication of pivotal clinical data for AlloSure Lung in Transplantation Direct and in Biomarker Insights. GlobeNewswire Inc

06:33AM EDT HC Wainwright & Co. Maintains Buy on CareDx, Raises Price Target to $45 Benzinga

Oct 1, 2020

10:15AM EDT CareDx Receives Final Medicare Coverage Decision For AlloSure Heart Benzinga

09:50AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced the release of the final local coverage determination by Palmetto MolDx for AlloSure Heart. GlobeNewswire Inc

Sep 24, 2020

07:00AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the launch of AlloCare at the CareDx organized AlloCare Transplant Festival on September 26, 2020. GlobeNewswire Inc

Sep 11, 2020

07:01AM EDT CareDx To Present Clinical Data At TTS 2020 Virtual Conference Sept. 13-15 Benzinga

07:00AM EDT CareDx Shares Latest Clinical Data at the TTS 2020 Virtual Conference GlobeNewswire Inc

Sep 2, 2020

07:00AM EDT CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today that the company plans to participate in two upcoming conferences. GlobeNewswire Inc

Aug 6, 2020

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Aug 5, 2020

07:18AM EDT Raymond James Maintains Strong Buy on CareDx, Raises Price Target to $42 Benzinga

06:13AM EDT HC Wainwright & Co. Maintains Buy on CareDx, Raises Price Target to $40 Benzinga

Aug 4, 2020

04:26PM EDT CareDx Q2 EPS $0.04 Beats $(0.04) Estimate, Sales $41.80M Beat $35.61M Estimate Benzinga

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Jul 30, 2020

07:00AM EDT CareDx to Participate at the Canaccord Genuity 40th Annual Growth GlobeNewswire Inc

Jul 16, 2020

04:05PM EDT CareDx to Report Second Quarter 2020 Financial Results GlobeNewswire Inc

Jul 15, 2020

07:00AM EDT CareDx Chairman and CEO Peter Maag to Present at Global Kidney GlobeNewswire Inc

.dark-mode .ZhzsqS{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ZhzsqS{ color: #333333; background-color: white; border: 2px solid #333333; }CDNACareDx, Inc.stock NASDAQ

CDNA
CareDx, Inc.
stock NASDAQ